Literature DB >> 1333275

Acute and chronic effects of lisinopril on renal and systemic hemodynamics in hypertension.

J P Degaute1, M Leeman, C Reuse, E Carlier, A Schoutens, P Vandepapeliere.   

Abstract

Acute and chronic effects of the converting enzyme inhibitor lisinopril on renal and systemic hemodynamics were studied in 12 patients with mild to moderate essential hypertension. After a washout period, cardiac output (measured by Doppler echography), renal plasma flow, and glomerular filtration rate (measured by isotopic techniques) were determined before and after oral administration of 20 mg lisinopril (visit 1). The same protocol was repeated after 3 months of lisinopril therapy 20 mg once daily (visit 2). Acute administration of lisinopril, both in untreated hypertensive patients (visit 1) and during long-term treatment (visit 2), decreased blood pressure (p < 0.05) and increased renal plasma flow (p < 0.05), while cardiac output and glomerular filtration rate were unchanged. Comparison of baseline parameters between visits 1 and 2 showed that chronic treatment with lisinopril decreased blood pressure and renal vascular resistance and that these effects were still significant 24-hours postdosage. We conclude that lisinopril is an effective antihypertensive agent with favorable renal hemodynamic effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333275     DOI: 10.1007/bf00055606

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  16 in total

1.  Immediate and short-term cardiovascular effects of a new converting enzyme inhibitor (lisinopril) in essential hypertension.

Authors:  G E Garavaglia; F H Messerli; B D Nunez; R E Schmieder; E D Frohlich
Journal:  Am J Cardiol       Date:  1988-11-01       Impact factor: 2.778

2.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.

Authors:  D E Hricik; P J Browning; R Kopelman; W E Goorno; N E Madias; V J Dzau
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

3.  The renal vasculature in early essential hypertension: evidence for a pathogenetic role.

Authors:  N K Hollenberg; L J Borucki; D F Adams
Journal:  Medicine (Baltimore)       Date:  1978-03       Impact factor: 1.889

4.  Sodium intake and renal responses to captopril in normal man and in essential hypertension.

Authors:  N K Hollenberg; L G Meggs; G H Williams; J Katz; J D Garnic; D P Harrington
Journal:  Kidney Int       Date:  1981-08       Impact factor: 10.612

5.  Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.

Authors:  G E Garavaglia; F H Messerli; B D Nunez; R E Schmieder; E D Frohlich
Journal:  Am J Hypertens       Date:  1988-07       Impact factor: 2.689

6.  Juxtaglomerular cells grown as monolayer cell culture contain renin, angiotensin I-converting enzyme, and angiotensin I and II/III.

Authors:  W A Rightsel; T Okamura; T Inagami; J A Pitcock; Y Takii; B Brooks; P Brown; E E Muirhead
Journal:  Circ Res       Date:  1982-06       Impact factor: 17.367

7.  Preserved renal perfusion during beta blockade by tertatolol with and without cyclooxygenase inhibition in normal humans.

Authors:  C Reuse; M Leeman; J P Degaute; M Abramowicz; J F Prost; R Naeije
Journal:  J Clin Pharmacol       Date:  1988-04       Impact factor: 3.126

8.  Renal and systemic hemodynamics in sustained essential hypertension.

Authors:  G M London; M E Safar; J E Sassard; J A Levenson; A C Simon
Journal:  Hypertension       Date:  1984 Sep-Oct       Impact factor: 10.190

9.  The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.

Authors:  E R Powers; K S Bannerman; J Stone; D S Reison; E L Escala; A Kalischer; M B Weiss; R R Sciacca; P J Cannon
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

10.  Improved renal function during chronic lisinopril treatment in moderate to severe primary hypertension.

Authors:  A G Dupont; P Van der Niepen; A Volckaert; M Ingels; A M Bossuyt; M H Jonckheer; R O Six
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

View more
  4 in total

Review 1.  Lisinopril. A review of its pharmacology and clinical efficacy in elderly patients.

Authors:  H D Langtry; A Markham
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

Review 2.  ACE inhibitors. Differential use in elderly patients with hypertension.

Authors:  Z H Israili; W D Hall
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

Review 3.  How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.

Authors:  Holly Digne-Malcolm; Matthew C Frise; Keith L Dorrington
Journal:  Front Physiol       Date:  2016-07-29       Impact factor: 4.566

4.  Dynamic tissue perfusion assessment reflects associations between antihypertensive treatment and renal cortical perfusion in patients with chronic kidney disease and hypertension.

Authors:  Arkadiusz Lubas; Grzegorz Kade; Marek Saracyn; Stanisław Niemczyk; Przemysław Dyrla
Journal:  Int Urol Nephrol       Date:  2018-01-27       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.